P. Venugopal

发表

Increased Proliferation and Analysis of Differential Gene Expression in Human Wharton's Jelly-derived Mesenchymal Stromal Cells under Hypoxia

Usha Nekanti, S. Dastidar, P. Venugopal, 2010, International journal of biological sciences.

Revealing Missing Human Protein Isoforms Based on Ab Initio Prediction, RNA-seq and Proteomics

D. Adelson, Bing Zhang, Chaochun Wei, 2015, Scientific Reports.

Splice factor mutations and alternative splicing as drivers of hematopoietic malignancy

H. Scott, P. Venugopal, C. Hahn, 2015, Immunological reviews.

Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applications.

Usha Nekanti, P. Venugopal, S. Totey, 2010, Stem cell research.

Higher propensity of Wharton's jelly derived mesenchymal stromal cells towards neuronal lineage in comparison to those derived from adipose and bone marrow

P. Venugopal, A. Majumdar, S. Balasubramanian, 2013, Cell biology international.

GATA2 deficiency syndrome: A decade of discovery

Anna L. Brown, H. Scott, P. Arts, 2021, Human mutation.

Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton’s jelly derived mesenchymal stem cells? A comparative study

P. Venugopal, Malancha Ta, A. Majumdar, 2014, Stem Cell Research & Therapy.

Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells.

P. Venugopal, Malancha Ta, A. Majumdar, 2012, Cytotherapy.

Characterisation of a compound in-cis GATA2 germline mutation in a pedigree presenting with myelodysplastic syndrome/acute myeloid leukemia with concurrent thrombocytopenia

H. Scott, M. Horwitz, P. Venugopal, 2015, Leukemia.

Self-reverting mutations partially correct the blood phenotype in a Diamond Blackfan anemia patient

R. D'Andrea, David M. Lawrence, L. To, 2017, Haematologica.

Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing loss

Anna L. Brown, H. Rienhoff, H. Scott, 2020, BMC Medical Genetics.

Glycosylation in SARS-CoV-2 variants: A path to infection and recovery

P. Venugopal, Arya Aloor, Renuka Suravajhala, 2022, Biochemical Pharmacology.

Clinical implications of transient myeloproliferative disorder in a neonate without Down syndrome features

T. Révész, H. Scott, P. Venugopal, 2017, Journal of paediatrics and child health.

Multiple functions of the scaffold protein Discs large 5 in the control of growth, cell polarity and cell adhesion in Drosophila melanogaster

Vincent Mirouse, H. Veyssière, P. Venugopal, 2020, BMC Developmental Biology.

Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton’s jelly derived mesenchymal stem cells? A comparative study

P. Venugopal, Malancha Ta, A. Majumdar, 2014, Stem Cell Research & Therapy.

Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes

Anna L. Brown, J. Matthews, H. Scott, 2017, Leukemia.

Stem Cells and Cloning: Advances and Applications Dovepress Isolation, Characterization, and Gene Expression Analysis of Wharton's Jelly-derived Mesenchymal Stem Cells under Xeno-free Culture Conditions

P. Venugopal, Malancha Ta, A. Majumdar, 2022 .

A Prox1 enhancer represses haematopoiesis in the lymphatic vasculature

H. Scott, A. Schreiber, P. Venugopal, 2023, Nature.

Australian Familial Haematological Cancer Study - Findings from 15 Years of Aggregated Clinical, Genomic and Transcriptomic Data

Anna L. Brown, H. Scott, A. Schreiber, 2019, Blood.

Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies

Anna L. Brown, M. Bishop, H. Scott, 2022, Blood advances.

Stem Cells and Cloning: Advances and Applications Dovepress Isolation, Characterization, and Gene Expression Analysis of Wharton's Jelly-derived Mesenchymal Stem Cells under Xeno-free Culture Conditions

P. Venugopal, Malancha Ta, S. Balasubramanian, 2022 .

Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansion

P. Arts, P. Venugopal, M. Jongmans, 2024, Blood advances.

Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41

S. Fröhling, M. Cazzola, J. Klco, 2023, Blood advances.